Post by Genmab

168,829 followers

#NewsUpdate: The European Commission has granted marketing authorization for one of our #BloodCancer therapies, developed in partnership with AbbVie, as a combination regimen for adult patients with relapsed/refractory (R/R) follicular #lymphoma (FL). Learn more: http://gmab.ly/qR9L50ZaGpR

Post content

Video Content